Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: Effect of clinical data on reader accuracy

被引:74
|
作者
Dhingsa, R
Qayyum, A
Coakley, FV
Lu, Y
Jones, KD
Swanson, MG
Carroll, PR
Hricak, H
Kurhanewicz, J
机构
[1] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA
关键词
diagnostic radiology; observer performance; magnetic resonance (MR); spectroscopy; prostate neoplasms;
D O I
10.1148/radiol.2301021562
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To determine the effect of digital rectal examination findings, sextant biopsy results, and prostate-specific antigen (PSA) levels on reader accuracy in the localization of prostate cancer with endorectal magnetic resonance (MR) imaging and MR spectroscopic imaging. MATERIALS AND METHODS: This was a retrospective study of 37 patients (mean age, 57 years) with biopsy-proved prostate cancer. Transverse T1-weighted, transverse high-spatial-resolution, and coronal T2-weighted MR images and MR spectroscopic images were obtained. Two independent readers, unaware of clinical data, recorded the size and location of suspicious peripheral zone tumor nodules on a standardized diagram of the prostate. Readers also recorded their degree of diagnostic confidence for each nodule on a five-point scale. Both readers repeated this interpretation with knowledge of rectal examination findings, sextant biopsy results, and PSA level. Step-section histopathologic findings were the reference standard. Logistic regression analysis with generalized estimating equations was used to correlate tumor detection with clinical data, and alternative free-response receiver operating characteristic (AFROC) curve analysis was used to examine the overall effect of clinical data on all positive results. RESULTS: Fifty-one peripheral zone tumor nodules were identified at histopathologic evaluation. Logistic regression analysis showed awareness of clinical data significantly improved tumor detection rate (P <.02) from 15 to 19 nodules for reader 1 and from 13 to 19 nodules for reader 2 (27%-37% overall) by using both size and location criteria. AFROC analysis showed no significant change in overall reader performance because there was an associated increase in the number of false-positive findings with awareness of clinical data, from 11 to 21 for reader 1 and from 16 to 25 for reader 2. CONCLUSION: Awareness of clinical data significantly improves reader detection of prostate cancer nodules with endorectal MR imaging and MR spectroscopic imaging, but there is no overall change in reader accuracy, because of an associated increase in false-positive findings. A stricter definition of a true-positive result is associated with reduced sensitivity for prostate cancer nodule detection. (C) RSNA, 2004.
引用
收藏
页码:215 / 220
页数:6
相关论文
共 50 条
  • [1] Localization of prostate cancer by endorectal MR imaging and MR spectroscopic imaging: Effect of clinical data on reader accuracy
    Dhingsa, R
    Coakley, FV
    Qayyum, A
    Kurhanewicz, J
    Yeh, BM
    Carroll, PR
    [J]. RADIOLOGY, 2002, 225 : 629 - 629
  • [2] Role of endorectal MR and MR spectroscopic imaging in the diagnosis of prostate cancer
    Costouros, NG
    Coakley, FV
    Qayyum, A
    Yeh, BM
    Joe, BN
    Kurhanewicz, J
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 184 (04) : 62 - 62
  • [3] Prostate cancer tumor volume: Measurement by endorectal MR imaging and MR spectroscopic imaging
    Coakley, FV
    Kurhanewicz, J
    Lu, Y
    Jones, KD
    Swanson, MG
    Chang, SD
    [J]. RADIOLOGY, 2001, 221 : 585 - 585
  • [4] Endorectal MR imaging and spectroscopic imaging of transition zone prostate cancer
    Eberhardt, SC
    Coakley, FV
    Schwartz, LH
    Zakian, KL
    Heinze, SB
    Hricak, H
    [J]. RADIOLOGY, 2001, 221 : 584 - 585
  • [5] Prostate cancer tumor volume: Measurement with endorectal MR and MR spectroscopic imaging
    Coakley, FV
    Kurhanewicz, J
    Lu, Y
    Jones, KD
    Swanson, MG
    Chang, SD
    Carroll, PR
    Hricak, H
    [J]. RADIOLOGY, 2002, 223 (01) : 91 - 97
  • [6] Clinical Stage T1c Prostate Cancer: Evaluation with Endorectal MR Imaging and MR Spectroscopic Imaging
    Zhang, Jingbo
    Hricak, Hedvig
    Shukla-Dave, Amita
    Akin, Oguz
    Ishill, Nicole M.
    Carlino, Lauren J.
    Reuter, Victor E.
    Eastham, James A.
    [J]. RADIOLOGY, 2009, 253 (02) : 425 - 434
  • [7] Endorectal MR and MR spectroscopic imaging of prostate cancer: Histopathological determinants of tumor visibility
    Hom, JJ
    Coakley, FV
    Simko, JP
    Qayyum, A
    Carroll, P
    Kurhanewicz, J
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 184 (04) : 62 - 62
  • [8] Predicting prostate cancer with dynamic endorectal coil MR and proton spectroscopic MR imaging
    Portalez, D
    Malavaud, B
    Herigault, G
    Lhez, JM
    Elman, B
    Jonca, F
    Besse, J
    Pradere, M
    [J]. JOURNAL DE RADIOLOGIE, 2004, 85 (12): : 1999 - 2004
  • [9] Prostate cancer: Prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging
    Yu, KK
    Scheidler, J
    Hricak, H
    Vigneron, DB
    Zaloudek, CJ
    Males, RG
    Nelson, SJ
    Carroll, PR
    Kurhanewicz, J
    [J]. RADIOLOGY, 1999, 213 (02) : 481 - 488
  • [10] Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging
    Fuetterer, Jurgen J.
    Heijmink, Stijn W. T. P. J.
    Scheenen, Tom W. J.
    Veltman, Jeroen
    Huisman, Henkjan J.
    Vos, Pieter
    Hulsbergen-Van de Kaa, Christina A.
    Witjes, J. Alfred
    Krabbe, Paul F. M.
    Heerschap, Arend
    Barentsz, Jelle O.
    [J]. RADIOLOGY, 2006, 241 (02) : 449 - 458